Tuesday, May 06, 2014 1:05:31 PM
source: http://www.businesswire.com/news/rxtimes/20140220005581/en/NanoViricides-Reports-Evaluating-Purchase-Facility-cGMP-Pilot
It takes years because it is transformational, breakthrough technology. No Big Pharma or other "loaded mule" toxic-compound making operation had the capabilities of producing our small company low toxicity and safe drug candidates, under the rigorous standards required for clinical trials.
source: http://www.nanoviricides.com/press%20releases/2014/NanoViricides%20Reports%20Novel%20Drug%20Candidates%20for%20Treatment%20of%20the%20MERS%20Middle%20East%20Respiratory%20Syndrome%20Corona%20Virus%20Ready%20For%20Animal%20Testing.html
We now have the capability to produce the FluCide candidate in sub-kg scale as well as kilogram scale! Oh, wow! Seems to me they are already testing our new state-of-the-art drug designing software/computers, interfacing instruments and nanoviricide producing equipment in our new GMP Pilot Plant in Shelton, CT. We are going to hit the road running!!!
And how about the GLP Toxicology and Safety Studies at BASi Indiana? Scale up is done!!!
How fast could this GLP tox and safety studies go?
source: http://www.pharmaceuticalonline.com/doc/why-you-should-consider-automated-in-vivo-0001
Ignition sequence start...!!!
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM